Bellecapital International Ltd. Makes New Investment in Synopsys, Inc. $SNPS

Bellecapital International Ltd. acquired a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS) during the third quarter, HoldingsChannel.com reports. The fund acquired 2,254 shares of the semiconductor company’s stock, valued at approximately $1,112,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in SNPS. Lionshead Wealth Management LLC raised its position in shares of Synopsys by 1.9% in the second quarter. Lionshead Wealth Management LLC now owns 914 shares of the semiconductor company’s stock valued at $469,000 after purchasing an additional 17 shares during the period. YANKCOM Partnership raised its holdings in Synopsys by 3.3% in the 2nd quarter. YANKCOM Partnership now owns 537 shares of the semiconductor company’s stock worth $275,000 after acquiring an additional 17 shares during the period. Manchester Capital Management LLC lifted its position in Synopsys by 5.3% during the 2nd quarter. Manchester Capital Management LLC now owns 340 shares of the semiconductor company’s stock worth $174,000 after acquiring an additional 17 shares during the last quarter. Hemington Wealth Management boosted its holdings in Synopsys by 10.1% during the second quarter. Hemington Wealth Management now owns 197 shares of the semiconductor company’s stock valued at $100,000 after acquiring an additional 18 shares during the period. Finally, Concord Asset Management LLC VA grew its position in shares of Synopsys by 0.8% in the second quarter. Concord Asset Management LLC VA now owns 2,379 shares of the semiconductor company’s stock valued at $1,220,000 after purchasing an additional 18 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms recently weighed in on SNPS. Wall Street Zen raised Synopsys from a “sell” rating to a “hold” rating in a research report on Saturday, December 13th. Weiss Ratings reiterated a “hold (c)” rating on shares of Synopsys in a report on Wednesday, October 8th. Needham & Company LLC raised their price objective on shares of Synopsys from $550.00 to $580.00 and gave the stock a “buy” rating in a research note on Thursday, December 11th. Piper Sandler cut their target price on shares of Synopsys from $630.00 to $602.00 and set an “overweight” rating for the company in a research note on Thursday, December 11th. Finally, Bank of America upgraded shares of Synopsys from an “underperform” rating to a “neutral” rating and decreased their price target for the stock from $525.00 to $500.00 in a research report on Monday, December 8th. Eleven equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $562.13.

Insiders Place Their Bets

In other news, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the sale, the chief financial officer owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 0.62% of the company’s stock.

Key Stores Impacting Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Analysts/commentary note Synopsys’ recent bounce and argue the shares could be attractive after the pullback; these narratives can support buying interest as investors re-evaluate valuation and growth prospects. Is Synopsys (SNPS) an Attractive Investment Choice?
• Positive Sentiment: Separate coverage focuses on an ~18% share rebound, asking whether the recovery leaves the stock undervalued — this kind of coverage can support momentum buyers. Synopsys (SNPS): Has the Recent 18% Share Price Rebound Left the Stock Undervalued?
• Neutral Sentiment: Reported short-interest data appears to show a 0-share figure and 0.0 days-to-cover — likely a data glitch and not a reliable signal for positioning. Treat this as non-actionable until confirmed by an exchange/shorts report.
• Negative Sentiment: Multiple law firms have announced class-action suits or investor alerts alleging securities fraud tied to a sharp prior stock drop; firms are soliciting lead plaintiffs with a looming Dec. 30, 2025 deadline. The alleged class period is Dec. 4, 2024 through Sept. 9, 2025; some filings cite a ~36% decline as the basis for claims. This concentrated legal publicity increases headline risk, potential litigation costs, and investor uncertainty — factors that can pressure the stock. Representative notices: KSF / Charles Foti 96-Hour Deadline Alert — BFA: Suit after 36% stock drop — Levi & Korsinsky notice

Synopsys Stock Performance

Synopsys stock opened at $477.14 on Friday. The firm has a market capitalization of $91.29 billion, a P/E ratio of 59.72, a P/E/G ratio of 3.97 and a beta of 1.16. The stock has a fifty day moving average price of $437.58 and a two-hundred day moving average price of $503.60. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52.

Synopsys (NASDAQ:SNPS) last issued its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, beating the consensus estimate of $2.79 by $0.11. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same quarter in the previous year, the company earned $3.40 EPS. The firm’s revenue for the quarter was up 37.8% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. As a group, analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.